Literature DB >> 1370189

Morphometric comparisons of optic nerve axon loss in acquired immunodeficiency syndrome.

W N Tenhula1, S Z Xu, M C Madigan, K Heller, W R Freeman, A A Sadun.   

Abstract

Axonal degeneration and diminution of the axonal population in the optic nerve have been documented in aging and in various neuro-ophthalmic conditions. We applied morphometric techniques to the postmortem examination of optic nerves obtained from patients with acquired immunodeficiency syndrome. Twelve optic nerves (eight from patients with AIDS and four from age-matched control eyes) were stained with paraphenylenediamine and morphometrically analyzed with a computer-assisted image and measurement system. Degeneration was often severe and was scattered throughout all of the AIDS-affected optic nerves. In the AIDS-affected optic nerves, the mean axonal population was markedly lower than the mean obtained from normal optic nerves (880,000 vs 1,507,000). Despite the approximate 40% loss of axons, mean axonal diameters were not markedly different, suggesting that no particular class of axon was especially susceptible to AIDS-associated degeneration. The extent and pattern of axonal loss in optic nerves of patients with AIDS suggest that the changes may not only be secondary to damage at the retina, but may reflect an AIDS-associated primary optic neuropathy.

Entities:  

Mesh:

Year:  1992        PMID: 1370189     DOI: 10.1016/s0002-9394(14)75746-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  22 in total

1.  Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS.

Authors:  Efe Sezgin; Sher L Hendrickson; Douglas A Jabs; Mark L Van Natta; Richard A Lewis; Jennifer L Troyer; Stephen J O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

2.  Association between retinal nerve fiber layer thickness and abnormalities of vision in people with human immunodeficiency virus infection.

Authors:  Partho S Kalyani; Gary N Holland; Amani A Fawzi; Tiago E F Arantes; Fei Yu; Alfredo A Sadun
Journal:  Am J Ophthalmol       Date:  2012-01-15       Impact factor: 5.258

3.  Neuro-ophthalmological disorders in HIV infected subjects with neurological manifestations.

Authors:  J-C Mwanza; L K Nyamabo; T Tylleskär; G T Plant
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

4.  Immunodetection of human immunodeficiency virus type 1 (HIV-1) Vpr in brain tissue of HIV-1 encephalitic patients.

Authors:  Elizabeth D A Wheeler; Cristian L Achim; Velpandi Ayyavoo
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

5.  Bilateral optic neuritis from acute HIV infection.

Authors:  Elizabeth Fortin; Howard M Heller; Jennifer Lyons; Sashank Prasad
Journal:  Neurol Clin Pract       Date:  2019-06

6.  Multifocal electroretinography in HIV-positive patients without infectious retinitis.

Authors:  Iryna A Falkenstein; Dirk-Uwe Bartsch; Stanley P Azen; Laurie Dustin; Alfredo A Sadun; William R Freeman
Journal:  Am J Ophthalmol       Date:  2008-02-15       Impact factor: 5.258

7.  Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin.

Authors:  H A Gelbard; H S Nottet; S Swindells; M Jett; K A Dzenko; P Genis; R White; L Wang; Y B Choi; D Zhang
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  AIDS-related optic neuropathy: a histological, virological and ultrastructural study.

Authors:  A A Sadun; J S Pepose; M C Madigan; K A Laycock; W N Tenhula; W R Freeman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-07       Impact factor: 3.117

9.  Analysis with support vector machine shows HIV-positive subjects without infectious retinitis have mfERG deficiencies compared to normal eyes.

Authors:  Michael H Goldbaum; Irina Falkenstein; Igor Kozak; Jiucang Hao; Dirk-Uwe Bartsch; Terrance Sejnowski; William R Freeman
Journal:  Trans Am Ophthalmol Soc       Date:  2008

Review 10.  HIV-related neuronal injury. Potential therapeutic intervention with calcium channel antagonists and NMDA antagonists.

Authors:  S A Lipton
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.